Publications
The mammalian cell cycle regulates parvovirus nuclear capsid assembly
Gil-Ranedo, J., Hernando, E., Riolobos, L., Domínguez, C., Kann, M., & Almendral, J. M. (2015). PLoS pathogens, 11(6), e1004920.
PMID: 26067441
Identification of metastasis-suppressive microRNAs in primary melanoma
Hanniford, D., Segura, M. F., Zhong, J., Philips, E., Jirau-Serrano, X., Darvishian, F., Berman, R. S., Shapiro, R. L., Pavlick, A. C., Brown, B., Osman, I., & Hernando, E. (2015). Journal of the National Cancer Institute, 107(3), dju494.
PMID: 25677173
Limited miR-17-92 overexpression drives hematologic malignancies
Danielson, L. S., Reavie, L., Coussens, M., Davalos, V., Castillo-Martin, M., Guijarro, M. V., Coffre, M., Cordon-Cardo, C., Aifantis, I., Ibrahim, S., Liu, C., *Koralov, S. B., & *Hernando, E. (2015). Leukemia research, 39(3), 335–341.
PMID: 25597017
BRD4 regulates embryonic stem cell identity by controlling transcriptional elongation of super-enhancer associated pluripotency genes
Di Micco, R., Fontanals-Cirera, B., Low, V., Ntziachristos, P., Yuen, S. K., Lovell, C. D., Dolgalev, I., Yonekubo, Y., Zhang, G., Rusinova, E., Gerona-Navarro, G., Cañamero, M., Ohlmeyer, M., Aifantis, I., Zhou, M. M., Tsirigos, A., & Hernando, E. (2014). Cell reports, 9(1), 234–247.
PMID: 25263550
Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients
Fleming, N. H., Zhong, J., da Silva, I. P., Vega-Saenz de Miera, E., Brady, B., Han, S. W., Hanniford, D., Wang, J., Shapiro, R. L., Hernando, E., & Osman, I. (2015). Cancer, 121(1), 51–59.
PMID: 25155861
Anti-miR-182 reduces ovarian cancer burden, invasion and metastasis: an in vivo study in orthotopic xenografts of nude mice
Xu, X., Ayub, B., Liu, Z., Serna, V. A., Qiang, W., Liu, Y., Hernando, E., Zabludoff, S., Kurita, T., Kong, B., & Wei, J. J. (2014). Molecular cancer therapeutics, 13(7), 1729–1739.
PMID: 24825857
Hedgehog pathway blockade inhibits melanoma cell growth in vitro and in vivo
O’Reilly, K. E., de Miera, E. V., Segura, M. F., Friedman, E., Poliseno, L., Han, S. W., Zhong, J., Zavadil, J., Pavlick, A., Hernando, E., & Osman, I. (2013). Pharmaceuticals (Basel, Switzerland), 6(11), 1429–1450.
PMID: 24287465
Clinicopathological characteristics at primary melanoma diagnosis at risk factors for brain metastasis
Qian, M., Ma, M. W., Fleming, N. H., Lackaye, D. J., Hernando, E., Osman, I., & Shao, Y. (2013). Melanoma research, 23(6), 461–467.
PMID: 24165034
BRD4 sustains proliferation and represents a new target for epigenetic therapy in melanoma
Segura, M. F., Fontanals-Cirera, B., Gaziel-Sovran, A., Guijarro, M. V., Hanniford, D., Zhang, G., González-Gomez, P., Morante, M., Jubierre, L., Zhang, W., Darvishian, F., Ohlmeyer, M., Osman, I., Zhou, M. M., & Hernando, E. (2013). Cancer research, 73(20), 6264–6276.
PMID: 23950209
Development and Characterization of a Clinically Relevant Mouse Model of Melanoma Brain Metastasis
Morsi, A., Gaziel-Sovran, A., Cruz-Munoz, W., Kerbel, R. S., Golfinos, J. G., Hernando, E., & Wadghiri, Y. Z. (2013). Pigment cell & melanoma research, 26(5), 743–745.
PMID: 23647875
Dual Pten/p53 suppression promotes sarcoma progression by triggering Notch signaling
Guijarro, M. V., Dahiya, S., Danielson, L. S., Segura, M. F., Vales-Lara, F. M., Menendez, S., Popiolek, D., Mittal, K., Wei, J. J., Zavadil, J., Cordon-Cardo, C., Pandolfi, P. P., & Hernando, E. (2013). The American journal of pathology, 182(6), 2015–2027.
PMID: 23708211